Find your next paid study

Children's Hospital of Orange CountyNCT07361536

Actual pay is set by the research site.

Phase 2

A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas

This phase II trial tests the safety, best dose, and effectiveness of epcoritamab when given with etoposide, cyclophosphamide, vincristine, doxorubicin, predni…

B-Cell Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311/BNT324 in subjects with advanced solid tumors.

Advanced Solid Tumors

DualityBio Inc.NCT05914116

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer …

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ferring PharmaceuticalsNCT06510374

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy…

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

National Cancer Institute (NCI)NCT04671667

~$75 – $1,800

Actual pay is set by the research site.

AgingDepressionCognitive Symptoms

Cognitive Enhancement in Recurrent Depression (The COG-D-R Study)

The goal of this clinical trial is to learn if a combination of non-drug treatments works to benefit memory, thinking, and brain functioning in older individua…

Vanderbilt University Medical CenterNCT07527273

Actual pay is set by the research site.

Phase 3

A Double-Masked, Randomized, Placebo-Controlled, Paired-Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Due to the c.2991+1655A>G (p.Cys998X) Mutation in the CEP290 Gene

The purpose of this double-masked, randomized, placebo-controlled, paired-eye study is to evaluate the efficacy, safety and tolerability of Sepofarsen in subje…

Leber Congenital Amaurosis 10BlindnessLeber Congenital Amaurosis+7 more

Laboratoires TheaNCT06891443

~$50 – $2,250

Actual pay is set by the research site.

Differential Absorption Kinetics of Grape Seed Extract Polyphenols: A Pilot Study

Grape seed extracts (GSEs) contain (poly)phenols that vary in their degree of polymerization, which may lead to differences in absorption, metabolism, and biol…

Healthy Adults

Clinical Nutrition Research Center, Illinois Institute of TechnologyNCT07886385

Actual pay is set by the research site.

Major Depressive Disorder

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System…

Motif Neurotech, Inc.NCT07594483

~$10 – $1,050

Actual pay is set by the research site.

Hematologic Malignancy Biology Study

This study will collect tumor samples from people with cancers of the blood, bone marrow, or lymph glands for laboratory study of the biology of these conditio…

Acute Lymphoblastic LeukemiaMyelodysplastic Syndrome (MDS)Non-Hodgkins Lymphoma+2 more

National Cancer Institute (NCI)NCT00923442

~$10 – $675

Actual pay is set by the research site.

Phase 3

An Extension Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig, Including Inhaled Corticosteroid Withdrawal, in Adults With Chronic Obstructive Pulmonary Disease (COPD) Who Completed Studies EFC18243 or EFC18244

This is an open-label, Phase 3, long-term safety extension study including participants of previous lunsekimig clinical trials with inadequately controlled chr…

Chronic Obstructive Pulmonary Disease

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07793409

Dental CariesDry MouthPeriodontal Diseases+1 more

Multi-Level Interventions to Reduce Oral Health Disparities Among Adults in Primary Care Settings

This study is a Stage III cRCT to test the efficacy of multi-level interventions at the practice- and provider-level to address low dental utilization (attenda…